[srp post_limit=”1″ widget_title=”” thumbnail_height=”300″ thumbnail_width=”300″ wp_thumbnail_size=”medium” ext_shortcodes_compatibility=”yes” post_content_length=”” post_content_length_mode=”” post_content_type=”” post_title_length_mode=”words” string_break=”” title_string_break=”” post_author_url=”no” post_category_link=”no” widget_title_hide=”yes” post_title_header=”h3″]

Aldatu Begins Offering COVID19 Testing Services for Health Care Providers, Employers and Schools

WATERTOWN, Mass., February 24, 2021 (PR Web) – Aldatu Biosciences, the leader in adaptive PCR diagnostics, announced the opening of new, expanded lab and R&D space in Watertown. The move to the new, 7,000-square-foot facility comes as demand grows for Aldatu’s unique PCR-based test for SARS-CoV-2, the virus that causes COVID19. Along with the move, Aldatu is launching a new service, Aldatu …
Read More
PANDAA qDx SARS-CoV-2

Aldatu Enables On-site COVID-19 Testing at Major Boston Hospital

(BOSTON, MA) — Despite national supply constraints, one of the major Boston hospitals now has the ability to do rapid in-house testing and they are conducting the highest volume of on-site hospital testing in New England, thanks to Boston-based startup, Aldatu Biosciences. Less than three weeks ago, the Aldatu team set to work on developing a test for COVID-19 detection. On Tuesday …
Read More

Aldatu Biosciences Expands PANDAA Platform Beyond HIV with SBIR for the First Pan-Lineage Lassa Fever Test

(BOSTON, MA) — Aldatu Biosciences, a biotechnology company developing molecular diagnostic assays and products based on gold standard real-time PCR, today announced it has been awarded a $300K Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH). The award will fund the continued advancement of the …
Read More

In Memory of Mark Wainberg: Aldatu Advisor and HIV Pioneer

It is with deep sadness that we pass along news of the sudden death of our friend, mentor, and Scientific Advisory Board member, Prof. Mark Wainberg. Mark was one of the earliest supporters of Aldatu and our efforts to bring PANDAA to patients, and for that he will always have our gratitude. His passing represents a tremendous loss for not only our …
Read More
Life Lab grand opening

Aldatu Biosciences Receives $3 Million SBIR Grant to Expand PANDAA-based HIV Drug Resistance Diagnostic Development

Boston, MA, 7th February 2016 (download press release .pdf) Aldatu Biosciences, an early-stage biotechnology company developing reagents and products for the diagnosis of drug-resistant HIV, today announced it has been awarded a Direct-to-Phase II Small Business Innovation Research (SBIR) grant for approximately $3,000,000 over three years. From the National Institute of Allergy and Infectious Disease (NIAID) at the National Institutes of Health (NIH), …
Read More